7 - Herbal Formulating for Cancer Care Flashcards

1
Q

What is the practice of herbal medicine considered to be?

A

Both an art and a science.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the key considerations in herbal formulating?

A
  • Safety and efficacy
  • Pharmacy (the form of medicine)
  • Posology (the dose and dosing frequency)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Who is attributed with the quote, ‘It is more important to know what kind of person has a disease than to know what kind of disease a person has’?

A

Hippocrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the predisposing causes of disease?

A
  • Genetics
  • Mental outlook and stress
  • Immune dysregulation
  • Nutrition
  • Physical trauma
  • Environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the excitatory or precipitating causes of disease?

A
  • Acute infection
  • Acute trauma
  • Acute exposure or sudden increased load of toxins
  • Radiation or drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are sustaining or perpetuating causes of disease?

A
  • Unresolved excitation
  • Inflammation
  • Senescence
  • Drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is allostasis?

A

A fundamental biological principle defined as a variable stability or dynamic equilibrium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the three levels of herbs in the Pyramid Prescribing Protocol?

A
  • Base or foundation
  • Synergistic or supportive
  • Specifics or targeted effectors and activators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are complementary herbs used for?

A
  • Systemic relaxants and circulatory stimulants
  • Antibiotics and immunostimulants
  • Hepatoprotectives and choleretics
  • Rubefacients and anti-inflammatories
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the main therapeutic intention in treating cancer?

A

Improve quality of life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is one strategy for increasing longevity in cancer care?

A

Delay or inhibit the progression of cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the activator or effector constituents in herbs?

A
  • Terpenes
  • Flavonoids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What should foundation interventions address in herbal treatment planning?

A
  • Extracellular area
  • Tumor microenvironment
  • Ongoing physiological enhancement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the goals of long-term maintenance protocols after conventional cancer care?

A
  • Support and sustain organ systems
  • Boost immune system
  • Optimize redox regulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What factors should be considered when creating a treatment protocol?

A
  • Specifics of the patient
  • Specifics of the cancer
  • Symptom-specific herbs
  • Coexisting health conditions
  • Anticipate drug interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fill in the blank: ‘What is there that is not poison? All things are poison and nothing is without poison. Solely the dose determines that a thing is not ______.’

17
Q

What is the difference between isolated constituents and whole herbs?

A

Variability in herbal products.

18
Q

What herb is known for its potential benefits in cancer treatment and is also a redox regulator?

19
Q

What are some supplements and herbs to use with caution if a patient is taking anticoagulants?

A

Specifics not provided in the text.

20
Q

True or False: There is a negligible risk from supplement interactions with chemotherapy.

21
Q

What are the risks associated with curcumin?

A

Specifics not provided in the text.

22
Q

What is one example of a herb that may have positive benefits when used alongside chemotherapy?

A

Ashwagandha

23
Q

What is a significant concern regarding antioxidant interactions in cancer treatment?

A

Unwarranted concerns about antioxidant interactions.